Soar Autism Center: Company Profile

Background

Overview

Soar Autism Center is a multidisciplinary healthcare provider specializing in early intervention services for children with autism. Established in 2020 by co-founders Ian and Jennifer Goldstein, the center is headquartered in Denver, Colorado, and operates multiple clinics across Colorado and Arizona. The organization is dedicated to delivering integrated, developmentally-appropriate autism care, emphasizing a child-centered approach that fosters learning through play, relationships, and natural routines.

Mission and Vision

The mission of Soar Autism Center is to transform autism care by providing every child with the opportunity to "soar." This vision is realized through a commitment to high-quality, compassionate therapy that places the child and family at the center of care.

Industry Significance

Operating within the healthcare sector, Soar Autism Center addresses the growing demand for specialized autism services, particularly in early childhood intervention. By offering a comprehensive suite of services under one roof, the center plays a pivotal role in enhancing accessibility and quality of care for families navigating autism therapy options.

Key Strategic Focus

Core Objectives

• Integrated Care Delivery: Provide a holistic approach to autism therapy by combining various disciplines to address the multifaceted needs of children with autism.

• Evidence-Based Practices: Implement therapies grounded in research, such as the Early Start Denver Model (ESDM), to ensure effective outcomes.

• Community Engagement: Establish deep connections within each community served to enhance service accessibility and relevance.

Areas of Specialization

• Early Childhood Intervention: Focus on children aged 1-5, offering therapies tailored to the developmental stages of young children.

• Comprehensive Therapy Services: Offer a range of services, including diagnostic testing, speech therapy, occupational therapy, ESDM-based ABA therapy, psychological care, and medical services.

Key Technologies Utilized

• ESDM-Based ABA Therapy: Utilize a play-based, developmentally appropriate approach to autism therapy that integrates principles from applied behavior analysis, developmental science, and relationship-based approaches.

• Integrated Care Model: Employ a collaborative team of professionals, including BCBAs, RBTs, OTs, SLPs, psychologists, and other mental health professionals, to deliver cohesive and personalized care.

Primary Markets Targeted

• Geographic Focus: Serve families in Colorado and Arizona, with plans for future expansion.

• Demographic Focus: Cater to families with children aged 1-5 diagnosed with autism, emphasizing early intervention.

Financials and Funding

Funding History

• Total Funds Raised: Approximately $54.96 million.

• Recent Funding Rounds:

• December 2025: Raised $17 million in a Series B-II funding round.

• 2024: Raised $19.3 million in a Series B-I funding round.

• 2022: Raised $16 million in a Series A funding round.

• 2021: Raised $2.3 million in an initial funding round.

Notable Investors

Specific investor details are not publicly disclosed.

Utilization of Capital

The funds are primarily allocated towards expanding service offerings, enhancing clinic facilities, and supporting the development and implementation of evidence-based therapies.

Pipeline Development

Key Pipeline Candidates

As a service-oriented organization, Soar Autism Center focuses on the continuous development and refinement of its therapeutic programs rather than traditional product pipelines.

Stages of Development

• Program Expansion: Ongoing development of new clinic locations and service offerings to meet the growing demand for autism therapy services.

• Therapy Enhancement: Continuous improvement and adaptation of therapeutic approaches to align with the latest research and best practices.

Target Conditions

• Autism Spectrum Disorder (ASD): Provide comprehensive care for children diagnosed with ASD, focusing on early intervention and skill development.

Anticipated Milestones

• Clinic Openings: Scheduled openings of new clinics in underserved areas to increase accessibility.

• Program Certifications: Achieving certifications and accreditations that validate the quality and effectiveness of therapeutic programs.

Technological Platform and Innovation

Proprietary Technologies

• ESDM-Based Therapy: Implement a proprietary, play-based therapy model that integrates principles from applied behavior analysis, developmental science, and relationship-based approaches.

Significant Scientific Methods

• Early Start Denver Model (ESDM): A developmentally appropriate, evidence-based therapy for young children with autism, focusing on social interactions, play, and relationships.

• Integrated Care Model: A collaborative approach involving a team of professionals working together to deliver cohesive and personalized autism care.

Leadership Team

Executive Profiles

• Ian Goldstein: Co-Founder and CEO. Background in public education and medicine, with a personal connection to autism care.

• Jennifer Goldstein: Co-Founder and Chief People Officer. Experienced in healthcare management and committed to fostering a supportive work environment.

• Ford Kerr: Head of AI & Automation. Leads the integration of technology to enhance service delivery and operational efficiency.

• Daniel Spiegel: Senior Vice President of Growth and Development. Focuses on strategic expansion and partnerships to drive organizational growth.

• Amanda Ariza: Vice President of Clinical Operations. Oversees the implementation and quality assurance of therapeutic programs.

• Will Martin: Senior Director of Care Model Design. Leads the development and refinement of care models to ensure evidence-based practices.

• Anne Bonomo: Director of People